[PLX] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 717.66%
YoY- 475.95%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 3,748 10,486 10,345 35,075 9,588 8,617 14,183 -58.78%
PBT -4,733 -6,426 -1,719 19,647 -2,936 -3,210 -3,567 20.72%
Tax -138 -382 133 308 195 530 442 -
NP -4,595 -6,044 -1,852 19,339 -3,131 -3,740 -4,009 9.51%
Tax Rate - - - -1.57% - - - -
Total Cost 8,343 16,530 12,197 15,736 12,719 12,357 18,192 -40.50%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -122.60 -57.64 -17.90 55.14 -32.66 -43.40 -28.27 165.69%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.06 -0.08 -0.03 0.29 -0.05 -0.07 -0.08 -17.43%
EPS Diluted -0.06 -0.08 -0.02 0.21 -0.05 -0.07 -0.08 -17.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.